COVID-19 vaccine for children after MIS-C appears safe

A study of children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications including myocarditis or MIS-C reoccurrence. About half of participants experienced mild and typical reactions, including arm soreness and fatigue. The study demonstrates that it is safe to get a vaccine after having MIS-C.
Read Original Article: COVID-19 vaccine for children after MIS-C appears safe »